CLEMENTIA PHARMACEUTICALS IN's ticker is CMTA and the CUSIP is 185575107. A total of 44 filers reported holding CLEMENTIA PHARMACEUTICALS IN in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2017 | $410,000 | – | 24,300 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Orbimed Advisors | 10,425,225 | $176,082,000 | 1.68% |
NEA Management Company, LLC | 2,141,697 | $36,173,000 | 1.27% |
RA Capital Management | 585,403 | $9,887,000 | 0.89% |
DAFNA Capital Management LLC | 60,000 | $1,013,000 | 0.63% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 819,508 | $13,841,000 | 0.54% |
EcoR1 Capital, LLC | 194,166 | $3,279,000 | 0.44% |
SPHERA FUNDS MANAGEMENT LTD. | 163,000 | $2,753,000 | 0.39% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 462,387 | $7,810,000 | 0.35% |
Rock Springs Capital Management LP | 345,000 | $5,827,000 | 0.27% |
Perceptive Advisors | 704,500 | $12,582,000 | 0.24% |